Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumor, Adult × patritumab deruxtecan × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasm Metastasis 1 Meningeal Neoplasms 1 Melanoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1 Brain Neoplasms 1

Interventions

Proton Therapy 3 pembrolizumab 2 spartalizumab 1 leronlimab 1 Valganciclovir 1 Radiotherapy 1 Paclitaxel 1 Lacteol 1 Interleukin-2 1 Docetaxel 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡